New York bills · 2025 Regular Session
New York A 10967
Enhances transparency in the prescription drug supply chain
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Jake Ryan Blumencranz (Republican/Conservative)
Summary
Official abstract published by the New York legislature
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 14, 2026 · House
REFERRED TO HEALTH